Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm to Proceed with Phase 3 Knee OA Trial

Nov 28, 2024 at 2:53 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment